Genelux (NASDAQ: GNLX)
$3.83
(10.1%)
$0.35
Price as of May 3, 2024, 4:00 p.m. ET
Genelux Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Genelux Company Info
Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.
News & Analysis
Featured Article
Why Shares of Genelux Climbed This Week
The company's shares rose on signs it might be getting closer to its first biologics license application.
Jim Halley | Jul 28, 2023
Featured Article
Why Shares of Genelux Corporation Jumped This Week
The company reported positive phase 2 trial news regarding its lead therapy.
Jim Halley | Jun 1, 2023
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.